NDC 59368-385 - Micardis HCT
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59368-385
- Package NDCs from labels
- 59368-385-01
- Manufacturer
- Praxis, LLC
- Effective date
- 2023-01-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Micardis HCT - Praxis, LLC | Praxis, LLC | 2023-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 48b4d633-ecfa-4748-80e8-6c0e3d8b067e | 2022-05-02 | Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | e0349fe8-90a4-4236-9686-f0c9c00a001c | 2022-05-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 2bcd9e20-2839-4cc0-9d1d-74b2cf17a96e | 2022-05-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL AND HYDROCHLOROTHIAZIDE | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | d9895efd-fb9d-4ce9-818a-31d724b16295 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | fd9b3e5a-f564-4730-8b9f-2cdc2953cbc9 | 2022-04-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | b54ec2b1-3325-46a1-b654-8a75dc41ab0a | 2022-03-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Quinapril and Hydrochlorothiazide 10/12.5 | QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 | Cipla USA Inc. | 1de5420c-23d6-40c5-ba24-39143c0f90fb | 2022-01-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 4c3403a6-da6a-4f37-bc7e-9fe0aa284305 | 2021-12-07 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Cipla USA Inc. | 40e6b627-63dc-4d52-aaa8-750663ad86c2 | 2021-11-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | b129e54a-a6d8-42c0-baac-e8db2487369b | 2021-11-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| triamterene and hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 236dead0-16d5-4383-860f-30743730a088 | 2021-10-28 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| candesartan cilexetil and hydrochlorothiazide | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | Solco Healthcare LLC | 543b9806-ccfa-4144-a2a2-d0e35eaceeee | 2021-05-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | f0b993f2-9771-42e3-b10e-09719189e2bd | 2021-01-19 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | f11598d2-87ee-4292-8631-c29c54f4dfa9 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 6be05675-c4b4-4e1e-9047-044a7fc7cef6 | 2021-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 97b09783-7bba-4f7a-b1b3-86ccf12c7ecc | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | a6e7d8a7-f969-4a21-ac28-93c77ed1fa63 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 75b3f944-b4fc-40a5-a4e2-aec2fbab64b8 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE | Teva Pharmaceuticals USA, Inc. | 5c128ef2-60a6-40f3-b37f-ee139fe27987 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 78c04f59-65c3-4a16-83a6-ed4a409afce5 | 2021-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.